Endothelial-Mesenchymal Transition or Functional Tissue Regeneration - Two Outcomes of Heart Remodeling

Physiol Res. 2021 Nov 30;70(Suppl 1):S13-S20.

Abstract

Heart remodeling occurs as a compensation mechanism for the massive loss of tissue during initial heart failure and the consequent inflammation process. During heart remodeling fibroblasts differentiate to myofibroblasts activate their secretion functions and produce elevated amounts, of extracellular matrix (ECM) proteins, mostly collagen, that form scar tissue and alter the normal degradation of ECM. Scar formation does replace the damaged tissue structurally; however, it impedes the normal contractive function of cardiomyocytes (CMs) and results in long-lasting effects after heart failure. Besides CMs and cardiac fibroblasts, endothelial cells (ECs) and circulating endothelial progenitor cells (cEPCs) contribute to heart repair. This review summarizes the current knowledge of EC-CM crosstalk in cardiac fibrosis (CF), the role of cEPCs in heart regeneration and the contribution of Endothelial-mesenchymal transition (EndoMT).

Publication types

  • Review

MeSH terms

  • Cicatrix / metabolism
  • Endothelial Progenitor Cells*
  • Extracellular Matrix Proteins
  • Fibroblasts / metabolism
  • Fibrosis
  • Heart Failure* / metabolism
  • Humans
  • Myocytes, Cardiac / physiology
  • Myofibroblasts / metabolism

Substances

  • Extracellular Matrix Proteins